The TSC Alliance endeavors to stimulate, support, and coordinate research that will lead to a cure for tuberous sclerosis complex (TSC) while improving the lives of those affected. In 2021 we anticipate awarding one or two postdoctoral fellowships and one or two research grants, depending on merit, requested budgets, and funds available. A description of research funded previously is available on the TSC Alliance grants webpage.
Key Dates
| Online submission for letters of intent (LOI) opens | Friday, March 19, 2021 |
| LOIs due | Monday, May 17, 2021 |
| Full proposal invitations distributed | Friday, June 25, 2021 |
| Full proposals due (by invitation only) | Monday, August 23, 2021 |
| Earliest project start date | Wednesday, December 1, 2021 |
Important Changes from Previous Cycles
- Applicants for either a Postdoctoral Fellowship or a Research Grant must fit the NIH definition of an Early-Stage Investigator (this change was implemented in 2020).
- Postdoctoral Fellowship applicants must have been a member of the Sponsor’s laboratory for at least 12 months as of the Letter of Intent due date.
- Previous recipients of a TSC Alliance Postdoctoral Fellowship are not eligible to receive a second TSC Alliance Postdoctoral Fellowship but may be eligible to receive a Research Grant as an independent, early-stage investigator.
- Emphasis on mentoring and anticipated impact of receiving a Postdoctoral Fellowship on the applicant’s career plans.
- The overall strength and innovation of the application are the primary considerations during peer review. At the second level of review, the TSC Alliance’s Science and Medical Committee of its Board of Directors will consider the results of peer review along with other factors to increase the ethnic and geographic diversity of TSC Alliance funding recipients.